(E)-1-(Tetrahydro-3-methyl-2,6-diphenylpyran-4-ylidene) thiosemicarbazide (3) and (E)-1-(2,6-bis(4-chlorophenyl)-tetrahydro-3,5-dimethylpyran-4-ylidene) thiosemicarbazide (4) were obtained and characterized by FT-IR, H-1 NMR, C-13 NMR, NOESY spectroscopy and X-ray single-crystal diffraction analysis. Molecular orbital calculations have been carried out for 3 and 4 by using an ab initio method (HF) and also density functional method (B3LYP) at 6-31G basis set. Compound 4 crystallizes in the monoclinic system, space group P2(1)/c, with a = 11.9645(3) angstrom, b = 20.0690(6) angstrom, c = 8.7441(2) angstrom, beta = 105.5220(10), V = 2023.02(9) angstrom(3), and Z = 4. Compounds 3 and 4 exist in chair conformation with equatorial orientation of all the substituents at pyran ring except the methyl group at C-5 of compound 4 which is oriented at axial disposition to stabilise the chair conformation and the configuration about the C=N double bond is syn to C-5 carbon (E-form). (c) 2010 Elsevier B.V. All rights reserved.
(E)-1-((Tetrahydro-3-methyl-2,6-diphenyl-pyran-4-ylidene))
硫基半自交腙(3)和(E)-1-(2,6-二(4-
氯苯基)环状-3,5-二甲基-四氢-3-位的环状 Trying Bifurcated M)
硫基半自交腙(4)通过FT-IR、一H-NMR、C-13-NMR、NOESY光谱分析和X射线晶体单晶衍射分析等方法制备并表征。3和4号化合物通过分子轨道计算法采用从头开始的HF方法和密度泛函方法B3LYP在6-31G基集进行了计算。4号化合物在斜方晶系中形成单晶,确定空间群为P2(1)/c,其a=11.9645(3)Å,b=20.0690(6)Å,c=8.7441(2)Å,beta=105.5220(10),V=2023.02(9)ų,和Z=4。3号和4号化合物位于椅式构型,并且环状上的所有取代基处于赤道式构型,其中4号化合物中的C-5甲基处于轴向构型,以稳定椅式构型,并且C=N双键与C-5碳符合(E)式。2010 Elsevier B.V. All rights reserved.